Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial - Murphy, JE; Wo, JY; Ryan, DP (JAMA Oncol, 2018)
et al.